Ophthalmology · New York, NY
NPI
1316961048
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
635 W 165th St, Box 92
New York, NY, 10032
Phone (212) 305-3039
Groups this clinician bills Medicare through
Medicare paid, 2024
$977K
6,140 services
Medicare patients, 2024
572
Average age 77
Drug cost, 2024
$274K
2,178 prescriptions
Company payments, 2025
$136
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas E Flynn was code 92134 (computerized ophthalmic imaging), 1,021 times for 380 patients. In total Thomas E Flynn billed 6,140 services in 21 codes, and Medicare paid $977K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 1,021 | 380 | $31.17 | $32K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,010 | 85 | $653.02 | $660K |
| 92012 Ophthalmological E&M | Office | 808 | 311 | $69.22 | $56K |
| 67028 Intravitreal Injection | Office | 730 | 130 | $86.65 | $63K |
| 92014 Ophthalmological E&M | Office | 472 | 462 | $80.78 | $38K |
| 92250 Angiography | Office | 435 | 414 | $24.38 | $11K |
| 92202 Ophthalmological E&M | Office | 356 | 242 | $12.02 | $4,280 |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 270 | 12 | $122.36 | $33K |
| J9035 Injection, bevacizumab, 10 mg | Office | 131 | 32 | $56.55 | $7,408 |
| 99212 Office E&M - Established | Office | 112 | 53 | $41.95 | $4,698 |
| 99214 Office E&M - Established | Office | 60 | 20 | $109.18 | $6,551 |
| 99204 Office E&M - New | Office | 58 | 58 | $116.45 | $6,754 |
| 99215 Office E&M - Established | Office | 30 | 15 | $172.92 | $5,187 |
By year: 2022 $1.1M for 6,208 services; 2023 $1.0M for 6,324 services; 2024 $977K for 6,140 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas E Flynn prescribed most often to Medicare patients was Ketorolac Tromethamine, with 379 prescriptions and refills. In total Thomas E Flynn wrote 2,178 Medicare prescriptions that cost $274K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketorolac Tromethamine Generic | 379 | 593 | 125 | $13K |
| Prednisolone Acetate Generic | 324 | 565 | 133 | $20K |
| Prednisone Generic | 235 | 441 | 60 | $2,222 |
| Methotrexate Methotrexate Sodium | 141 | 249 | 38 | $2,884 |
| Brimonidine Tartrate Generic | 134 | 276 | 42 | $13K |
| Timolol Maleate Generic | 127 | 269 | 40 | $1,855 |
| Dorzolamide Hcl Generic | 78 | 142 | 29 | $1,075 |
| Fluorometholone Generic | 70 | 129 | 27 | $6,903 |
| Combigan Brimonidine Tartrate/Timolol | 65 | 114 | 15 | $28K |
| Bromfenac Sodium Generic | 63 | 69 | 16 | $9,558 |
| Difluprednate Generic | 62 | 80 | 15 | $8,904 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 59 | 113 | 18 | $1,023 |
| Acyclovir Generic | 44 | 118 | 12 | $1,837 |
| Bromsite Bromfenac Sodium | 35 | 60 | Under 11 | $22K |
| Simbrinza Brinzolamide/Brimonidine Tart | 31 | 33 | Under 11 | $5,957 |
Brand drugs: 775 claims; generic drugs: 1,403 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas E Flynn $136 ($136 in general payments such as food, travel and fees) from 3 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $86.34.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.